Literature DB >> 19204904

Association of marijuana use and the incidence of testicular germ cell tumors.

Janet R Daling1, David R Doody, Xiaofei Sun, Britton L Trabert, Noel S Weiss, Chu Chen, Mary L Biggs, Jacqueline R Starr, Sudhansu K Dey, Stephen M Schwartz.   

Abstract

BACKGROUND: The incidence of testicular germ cell tumors (TGCTs) has been increasing the past 4 to 6 decades; however, exposures that account for this rise have not been identified. Marijuana use also grew during the same period, and it has been established that chronic marijuana use produces adverse effects on the human endocrine and reproductive systems. In this study, the authors tested the hypothesis that marijuana use is a risk factor for TGCT.
METHODS: A population-based, case-control study of 369 men ages 18 to 44 years who were diagnosed with TGCT from January 1999 through January 2006 was conducted in King, Pierce and Snohomish Counties in Washington State. The responses of these men to questions on their lifetime marijuana use were compared with the responses of 979 age-matched controls who resided in the same 3 counties during the case diagnosis period.
RESULTS: Men with a TGCT were more likely to be current marijuana smokers at the reference date compared with controls (odds ratio [OR], 1.7; 95% confidence interval [95% CI], 1.1-2.5). In analyses according to histologic type, most of the association between current marijuana use and TGCT was observed in men who had nonseminomas/mixed histology tumors (current use: OR, 2.3; 95% CI, 1.3-4.0). Age at first use among current users (age<18 years [OR, 2.8] vs age>or=18 years [OR, 1.3]) and frequency of use (daily or weekly [OR, 3.0] vs less than once per week [OR, 1.8]) appeared to modify the risk.
CONCLUSIONS: An association was observed between marijuana use and the occurrence of nonseminoma TGCTs. Additional studies of TGCTs will be needed to test this hypothesis, including molecular analyses of cannabinoid receptors and endocannabinoid signaling, which may provide clues regarding the biologic mechanisms of TGCTs. Copyright (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19204904      PMCID: PMC2759698          DOI: 10.1002/cncr.24159

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  39 in total

Review 1.  The surveillance, epidemiology, and end results program: a national resource.

Authors:  B F Hankey; L A Ries; B K Edwards
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

Review 2.  The molecular logic of endocannabinoid signalling.

Authors:  Daniele Piomelli
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

3.  Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells.

Authors:  Mauro Maccarrone; Sandra Cecconi; Gianna Rossi; Natalia Battista; Riccardo Pauselli; Alessandro Finazzi-Agrò
Journal:  Endocrinology       Date:  2003-01       Impact factor: 4.736

4.  Depression of plasma testosterone levels after chronic intensive marihuana use.

Authors:  R C Kolodny; W H Masters; R M Kolodner; G Toro
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

Review 5.  Cannabinoids: potential anticancer agents.

Authors:  Manuel Guzmán
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

6.  Trends in the incidence of testicular germ cell tumors in the United States.

Authors:  Katherine A McGlynn; Susan S Devesa; Alice J Sigurdson; Linda M Brown; Lilian Tsao; Robert E Tarone
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

Review 7.  Molecular biology of cannabinoid receptors.

Authors:  Beat Lutz
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

8.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

9.  [The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)].

Authors:  P N Post; M K Casparie; F J ten Kate; J W Oosterhuis
Journal:  Ned Tijdschr Geneeskd       Date:  2004-06-05

10.  Familial risk in testicular cancer as a clue to a heritable and environmental aetiology.

Authors:  K Hemminki; X Li
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more
  50 in total

1.  Marijuana use and testicular germ cell tumors.

Authors:  Britton Trabert; Alice J Sigurdson; Anne M Sweeney; Sara S Strom; Katherine A McGlynn
Journal:  Cancer       Date:  2010-10-05       Impact factor: 6.860

Review 2.  Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.

Authors:  Dragan M Svrakic; Patrick J Lustman; Ashok Mallya; Taylor Andrea Lynn; Rhonda Finney; Neda M Svrakic
Journal:  Mo Med       Date:  2012 Mar-Apr

Review 3.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

4.  Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.

Authors:  Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

5.  International trends in the incidence of testicular cancer, 1973-2002.

Authors:  Victoria M Chia; Sabah M Quraishi; Susan S Devesa; Mark P Purdue; Michael B Cook; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

Review 6.  An epidemiologic review of marijuana and cancer: an update.

Authors:  Yu-Hui Jenny Huang; Zuo-Feng Zhang; Donald P Tashkin; Bingjian Feng; Kurt Straif; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01       Impact factor: 4.254

7.  Consumption of alcoholic beverages in adolescence and adulthood and risk of testicular germ cell tumor.

Authors:  Mary L Biggs; David R Doody; Britton Trabert; Jacqueline R Starr; Chu Chen; Stephen M Schwartz
Journal:  Int J Cancer       Date:  2016-08-16       Impact factor: 7.396

Review 8.  Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers.

Authors:  Shreyas Gandhi; Gaurav Vasisth; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2017-04-11       Impact factor: 1.862

Review 9.  Marijuana: respiratory tract effects.

Authors:  Kelly P Owen; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

10.  Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk.

Authors:  John Charles A Lacson; Joshua D Carroll; Ellenie Tuazon; Esteban J Castelao; Leslie Bernstein; Victoria K Cortessis
Journal:  Cancer       Date:  2012-09-10       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.